Pediatric burns in the Bedouin population in southern Israel

Arnon D Cohen1, R Gurfinkel, R Glezinger

  • 1Clalit Health Services, Ben-Gurion University of the Negev, Beer-Sheva, Israel. arcohen@clalit.org.il

Thescientificworldjournal
|November 28, 2007
PubMed

Insights

Pediatric burn injuries are a significant public health issue for Bedouin children in the Negev. Scald burns are the most common cause, highlighting the need for enhanced prevention strategies.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Burn trauma presents a significant public health concern, particularly for pediatric populations.
  • Children, especially within the Bedouin community of the Negev, face elevated risks of burn injuries.

Purpose of the Study:

  • To delineate the epidemiological characteristics of burn injuries in hospitalized Bedouin children.
  • To identify key risk factors associated with pediatric burns in this specific demographic.

Main Methods:

  • A cross-sectional study was conducted at Soroka University Medical Center.
  • Data were collected from hospitalized burn patients between 2001 and 2002, focusing on 282 identified Bedouin children.

Main Results:

  • Scald injuries accounted for the majority of burns (67.4%), followed by fire (28.4%).
  • Most pediatric burn patients (94.0%) had injuries affecting less than 20% of their body surface area.
  • The mean hospitalization duration was 9.8 days, with two fatalities from fire-related burns.

Conclusions:

  • Pediatric burn injuries represent a substantial public health problem within the Bedouin population of the Negev.
  • Increased efforts in burn prevention are crucial to mitigate the impact of these injuries.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...